Fundstrat’s Tom Lee called Bitcoin’s (CRYPTO: BTC) 50% drawdown a “crypto squall” rather than a structural collapse, arguing technology and crypto sectors could revive as tariff uncertainty lifts. The Squall vs. Winter Thesis Lee told CNBC on Friday that Bitcoin’s decline stems from macro shocks, not fundamental weakness in blockchain networks. He pointed to parabolic […]
White House Pushes Trump’s Ban on Investors with 100+ Single-Family Homes: Report
The White House is stepping up efforts to implement President Donald Trump‘s proposed ban on investors buying homes. A memo outlining the plan has been sent to House and Senate committee leaders, targeting investors who own more than 100 single-family homes and restricting them from acquiring additional properties, The Wall Street Journal reported on Thursday. The […]
Eli Lilly’s Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients
Eli Lilly and Co. (NYSE:LLY) on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo (selpercatinib). The trial demonstrated a highly statistically significant improvement in event-free survival for patients with early-stage non-small cell lung cancer. Lung Cancer Trial Shows Benefit The LIBRETTO-432 trial results showed that selpercatinib significantly reduced the […]
Elon Musk Blasts xAI Rival Anthropic As ‘Misanthropic and Evil’ As the Startup Closes $30 Bil
On Thursday, Elon Musk slammed AI startup Anthropic for alleged bias and misanthropy after the company announced a $30 billion funding round, pushing its valuation to $380 billion. Anthropic Surges To $380 Billion Valuation The $380 billion post-money valuation marks more than a twofold increase from September. In a blog post, Anthropic reported a run-rate […]
Upstream Bio Shows Asthma Drug Cuts Attacks By 56%, Stock Reacts
Upstream Bio, Inc. (NASDAQ:UPB) shares were trading higher during Wednesday’s premarket session following positive results from the Phase 2 VALIANT trial of verekitug, a treatment for severe asthma. The stock gave up its gains and is falling, probably on profit booking. Asthma Trial Data The VALIANT trial demonstrated statistically significant reductions in the annualized asthma […]
Elon Musk’s Moon City Runs On AI — And These Chip Stocks Power It
Elon Musk‘s moon-first pivot isn’t just a space story — it’s an industrial and chip story that investors can actually own today. While headlines focus on rockets, the real build-out sits in silicon: high-performance computing, power-efficient chips, and satellite networking that make SpaceX‘s vision operational. Musk says SpaceX can launch to the moon every 10 […]
Amazon Defends Massive AI Spending
On Thursday, Amazon.com, Inc. (NASDAQ:AMZN) pushed back against Wall Street’s growing skepticism over soaring AI-related capital expenditures. Amazon Pushes Back On AI CapEx Concerns During the company’s fourth-quarter earnings call, Amazon addressed investor concerns around its aggressive spending on AI and data center infrastructure, arguing the investments are already producing returns. Responding to questions from […]
Uber Hits 200 Million Monthly Users, Hires New CFO
Uber Technologies, Inc. (NYSE:UBER) stock gained on Wednesday after the company reported its fiscal fourth-quarter 2025 results. The company reported a 20% year-over-year (Y/Y) revenue growth to $14.37 billion, surpassing the analyst consensus estimate of $14.32 billion. Uber reported adjusted EPS of 71 cents, which missed the analyst consensus estimate of 80 cents. Key Metrics Revenue from Mobility grew to […]
Newsletter
GameStop Is Back — What’s Fueling the 2025 Comeback?
June 18, 2025
Introduction GameStop Corp. (NYSE: GME) is once again making headlines in 2025, not just as a meme stock phenomenon, but as a company mounting a potentially serious turnaround. After years of volatility and skepticism, the stock has rallied more than 70% year-to-date—fueled by a new business strategy, improved financial performance, and a renewed wave of […]
Read More